ADVISORY, Nov. 20, 2006 (PRIMEZONE) --
What: The NASDAQ Stock Market will host an industry panel
luncheon and discussion focused on new research in the
fight against Acquired Immunodeficiency Syndrome (AIDS).
The panel will include industry experts and executives
from NASDAQ-listed Biotechnology companies that will
cover an array of industry topics ranging from prevention
and viral resistance, to quality of life treatments.
Following the panel discussion, there will be a NASDAQ
Closing Bell Ceremony in honor of World AIDS Day with
our panel members and NASDAQ representatives.
Who: Moderator:
---------
-- Emilio A. Emini, Ph.D. Executive Vice President,
Vaccine Research and Development for Wyeth
Pharmaceuticals
Panelists:
---------
-- Geoff Allan, Chief Executive Officer, President and
Chief Executive Officer of Insmed Incorporated
(Nasdaq:INSM)
-- Paul J. Maddon, M.D., Ph.D., Founder, Chief Executive
Officer and Chief Science Officer, Progenics
Pharmaceuticals, Inc. (Nasdaq:PGNX)
-- Douglas A. Michels, President & Chief Executive
Officer at OraSure Technologies, Inc. (Nasdaq:OSUR)
-- George Usher, Chairman, President and Chief Executive
Officer, Polydex Pharmaceuticals Limited (Nasdaq:POLXF).
When: Friday, December 1st, 2006
1:30 p.m. - 2:00 p.m. - Lunch
2:00 p.m. - 3:30 p.m. - Panel Discussion
3:30 p.m. - 4:00 p.m. - NASDAQ Closing Bell
Reporters, analysts, and other industry members are welcome
to attend.
Where: NASDAQ MarketSite
4 Times Square (Corner of 43rd and Broadway)
New York, NY
Contacts: Silvia Davi
646-441-5014
silvia.davi@nasdaq.com
Jolene Libretto
646-441-5220
Jolene.libretto@nasdaq.com
RSVP: Interested parties should RSVP to Jolene Libretto
Jolene.libretto@nasdaq.com
NASDAQ is the largest U.S. electronic stock market. With approximately 3,200 companies, it lists more companies and, on average, trades more shares per day than any other U.S. market. It is home to companies that are leaders across all areas of business including technology, retail, communications, financial services, transportation, media and biotechnology. NASDAQ is the primary market for trading NASDAQ-listed stocks. For more information about NASDAQ, visit the NASDAQ Web site at http://www.nasdaq.com or the NASDAQ Newsroom at http://www.nasdaq.com/newsroom/ .